Matisse Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-925
Closed -$305K 176
2025
Q4
$305K Buy
925
+7
+0.8% +$2.37K 0.14% 142
2025
Q3
$317K Buy
918
+7
+0.8% +$2.12K 0.14% 139
2025
Q2
$284K Hold
911
0.13% 147
2025
Q1
$477K Sell
911
-19
-2% -$9.71K 0.25% 110
2024
Q4
$470K Hold
930
0.24% 112
2024
Q3
$544K Hold
930
0.26% 110
2024
Q2
$474K Hold
930
0.23% 120
2024
Q1
$460K Sell
930
-4
-0.4% -$2.03K 0.22% 127
2023
Q4
$492K Buy
+934
New +$498K 0.26% 124
2023
Q3
Sell
-930
Closed -$447K 178
2023
Q2
$447K Hold
930
0.28% 118
2023
Q1
$440K Hold
930
0.28% 117
2022
Q4
$493K Buy
+930
New +$493K 0.44% 76
2022
Q3
Sell
-1,330
Closed -$683K 127
2022
Q2
$683K Buy
1,330
+400
+43% +$201K 0.65% 54
2022
Q1
$474K Buy
930
+180
+24% +$86.8K 0.44% 65
2021
Q4
$377K Hold
750
0.26% 102
2021
Q3
$293K Hold
750
0.11% 128
2021
Q2
$300K Hold
750
0.09% 122
2021
Q1
$279K Hold
750
0.08% 138
2020
Q4
$263K Hold
750
0.08% 128
2020
Q3
$234K Hold
750
0.09% 118
2020
Q2
$221K Buy
+750
New +$215K 0.07% 132
2020
Q1
Sell
-750
Closed -$220K 196
2019
Q4
$220K Buy
+750
New +$196K 0.16% 97

Other funds holding UNH

Matisse Capital's UNH Position: Q1 2026 in Review

Matisse Capital sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 925 shares — an estimated $305K sold.

Matisse Capital first reported a position in UNH in Q4 2019 and held it in 22 quarters. The position peaked at $683K in Q2 2022. 3,024 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Matisse Capital reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
  • Matisse Capital sold 925 UnitedHealth shares in Q1 2026, an estimated $305K.
  • Matisse Capital first reported a position in UnitedHealth in Q4 2019 and held it in 22 quarters.
  • Matisse Capital's UnitedHealth position peaked at $683K in Q2 2022.
  • 3,024 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Matisse Capital's 13F filing for Q1 2026, filed 8 May 2026.